HFOT (High flow with tracheostomy interface) for Chronic Obstructive Pulmonary Disease (COPD)

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Chronic Obstructive Pulmonary Disease (COPD)+2 MoreHFOT using AIRVO2 - Device
Eligibility
18 - 100
All Sexes
What conditions do you have?
Select

Study Summary

Patients undergoing major head and neck surgery are at risk for postoperative pulmonary complications. The goal of this randomized clinical trial is to evaluate the effectiveness of high flow heated humidified oxygen at preventing postoperative pulmonary complications after major head and neck surgery, when compared to conventional oxygen therapy (aerosol cool mist).

Eligible Conditions
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Day 14

Day 14
Incidence of post-operative pulmonary complication

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

COT (Conventional Oxygen Therapy)
1 of 2
HFOT (High flow with tracheostomy interface)
1 of 2

Active Control

Experimental Treatment

214 Total Participants · 2 Treatment Groups

Primary Treatment: HFOT (High flow with tracheostomy interface) · No Placebo Group · N/A

HFOT (High flow with tracheostomy interface)
Device
Experimental Group · 1 Intervention: HFOT using AIRVO2 · Intervention Types: Device
COT (Conventional Oxygen Therapy)
Device
ActiveComparator Group · 1 Intervention: COT · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: day 14

Who is running the clinical trial?

Fisher and Paykel HealthcareIndustry Sponsor
110 Previous Clinical Trials
8,470 Total Patients Enrolled
14 Trials studying Chronic Obstructive Pulmonary Disease (COPD)
578 Patients Enrolled for Chronic Obstructive Pulmonary Disease (COPD)
University of FloridaLead Sponsor
1,251 Previous Clinical Trials
698,599 Total Patients Enrolled
4 Trials studying Chronic Obstructive Pulmonary Disease (COPD)
95 Patients Enrolled for Chronic Obstructive Pulmonary Disease (COPD)
Rui Fernandes, MD, DMDPrincipal InvestigatorUniversity of Florida
3 Previous Clinical Trials
20 Total Patients Enrolled

Eligibility Criteria

Age 18 - 100 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have had a major head and neck surgery.